The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

Under the Healthcare Common Procedure Coding System (HCPCS), the Q-code Q9999 is for “Injection, for subcutaneous ... of latent infections. Serious bacterial, mycobacterial, fungal, and viral ...

Approved presentations of SELARSDI are 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous ... of latent infections. Serious bacterial, mycobacterial, fungal, and viral ...

offers systemic treatment that addresses yeast overgrowth throughout the body with a single dose. This approach proves particularly effective for stubborn infections or cases involving multiple ...

Guns and flames help the characters survive onscreen. In the real world, fighting fungal infections is less action-packed, but no less fraught. At the heart of the show is Ellie (Bella Ramsey), a ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

MISSOULA, Mont. — Health officials in Montana confirmed the state's first-ever case of the fungal infection Candida auris this week. The fungal infection is multidrug resistant and is most often ...